EWA
SGMO

EverSource Wealth Advisors’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

EverSource Wealth Advisors’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-328
Closed -$2K – 1870
2022
Q1 		$2K Buy
+328
New +$1.95K ﹤0.01% 1573

Other funds holding SGMO

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

EverSource Wealth Advisors's SGMO Position: Q2 2022 in Review

EverSource Wealth Advisors sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2022, closing a stake of 328 shares — an estimated $2K sold.

EverSource Wealth Advisors first reported a position in SGMO in Q1 2022 and held it in 1 quarter. The position peaked at $2K in Q1 2022. 188 funds tracked by Wall St. Rank hold SGMO as of Q2 2022.

  • EverSource Wealth Advisors reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2022 after selling out during the quarter.
  • EverSource Wealth Advisors sold 328 SANGAMO THERAPEUTICS INC shares in Q2 2022, an estimated $2K.
  • EverSource Wealth Advisors first reported a position in SANGAMO THERAPEUTICS INC in Q1 2022 and held it in 1 quarter.
  • EverSource Wealth Advisors's SANGAMO THERAPEUTICS INC position peaked at $2K in Q1 2022.
  • 188 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2022.

Based on EverSource Wealth Advisors's 13F filing for Q2 2022, filed 1 Aug 2022.